Bennett Chin, MD

Professional Titles

• Professor

Publications

• Synthesis and Preliminary Evaluation of 5-[18F]fluoroleucine. Chin BB, McDougald D, Weitzel DH, Hawk T, Reiman RE, Zalutsky MR, Vaidyanathan G. Curr Radiopharm. 2017;10(1):41-50. doi: 10.2174/1874471009666161230114954. PMID: 28034351
• PMID: 30291194
• PMID: 30291194
• Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo VA, Mahmood S, Wong V, Jimenez C. Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. J Nucl Med. 2019 May;60(5):623-630. PubMed PMID: 30291194
• Morgan R, Chin BB, Lanning R. Feasibility of rapid integrated radiation therapy planning with follow-up FDG PET/CT to improve overall treatment assessment in head and neck cancer. Am J Nucl Med Mol Imaging. 2019;9(1):24-29. PubMed PMID: 30911435
• McNamara MA, Oyekunle T, Chin BB, Oldan J, Anand A, Ritz M, Shantzer L, Anand M, Armstrong AJ, George DJ. Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer. Prostate. 2019 Jul;79(10):1106-1116. PubMed PMID: 31045266
• Liu Y, Carpenter AB, Pirozzi CJ, Yuan H, Waitkus MS, Zhou Z, Hansen L, Seywald M, Odion R, Greer PK, Hawk T, Chin BB, Vaidyanathan G, Zalutsky MR, Yan H, Vo-Dinh T. Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe. Nanotechnology. 2019 Jul 5;30(27):275101. PubMed PMID: 30856613
• Schmidt MQ, Trenbeath Z, Chin BB. Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor. World J Nucl Med. 2019 Jul-Sep;18(3):304-306. PubMed PMID: 31516377
• Silosky MS, Karki R, Morgan R, Anderson J, Chin BB. Physical characteristics of 68Ga DOTATATE PET/CT affecting small lesion detectability. American Journal Nuclear Medicine and Molecular Imaging 2021, in press.
• Moses K, Silosky M, Karki R, and Chin BB. 68Ga DOTATATE Tumor Uptake: Pheochromocytomas and Paragangliomas Versus Pancreatic and Small Bowel Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine 2020; 61: 3033
• 2. Jimenez C, Chin BB, Richard B. Noto, Joseph Stephen Dillon, Lilja B. Solnes, Vincent A. DiPippo, Nancy Stambler, Vivien Wong, Daniel A. Pryma, A Multi-Center, Open-Label, Pivotal Phase 2 Study of Azedra® (HSA I-131-MIBG) in Patients with Unresectable, Locally Advanced or Metastatic Pheochromocytoma orParaganglioma: Updated Long-Term Survival and Safety. Endocrine Society 2020. March 30, 2020
• Wehrend J, Silosky M, Xing F, Chin BB. Automated liver lesion detection in (68)Ga DOTATATE PET/CT using a deep fully convolutional neural network. EJNMMI Res. 2021 Oct 2;11(1):98. PubMed PMID: 34601660
• Silosky MS, Patten LW, Chin BB. Small target repeatability of (68)Ga and (18)F: effects of target concentration and imaging time on SUV measurements in clinically relevant phantoms. Am J Nucl Med Mol Imaging. 2021;11(4):280-289. PubMed PMID: 34513281
• Silosky MS, Karki R, Morgan R, Anderson J, Chin BB. Physical characteristics of (68)Ga DOTATATE PET/CT affecting small lesion detectability. Am J Nucl Med Mol Imaging. 2021;11(1):27-39. PubMed PMID: 33688453
• Jimenez C, Chin BB, Noto RB, Dillon JS, Solnes L, Stambler N, DiPippo VA, Pryma DA. Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma. Endocr Relat Cancer. 2023 Feb 1;30(2). PubMed PMID: 36472300
• Parent EE, Savir-Baruch B, Gayed IW, Almaguel F, Chin BB, Pantel AR, Armstrong E, Morley A, Ippisch RC, Flavell RR. (177)Lu-PSMA Therapy. J Nucl Med Technol. 2022 Sep;50(3):205-212. PubMed PMID: 36215646
• Grey N, Silosky M, Lieu CH, Chin BB. Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors. World J Gastroenterol. 2022 May 7;28(17):1768-1780. PubMed PMID: 35633909
• Yang X, Chin BB, Silosky M, Wehrend J, Litwiller D, Ghosh D, Xing F. Learning without Real Data Annotations to Detect Hepatic Lesions in PET Images. IEEE Transactions on Biomedical Engineering. 2022:submitted
• Lin EP, Chin BB, Fishbein L, Moritani T, Montoya SP, Ellika S and Newlands S. Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations. Radiology: Imaging Cancer. 2022;4:e210088.
• Silosky M XF, Wehrend J, Litwiller DV, Metzler SD, Chin BB. Modeling Contrast-to-Noise Ratio from List Mode Reconstructions of 68Ga DOTATATE PET/CT: Predicting Detectability of Hepatic Metastases in Shorter Acquisition PET Reconstructions. American journal of nuclear medicine and molecular imaging. 2022:in press
• Xing FS, M. ; Ghosh, D.; Chin, BB. Location-Aware Encoding for Lesion Detection in 68Ga-DOTATATE Positron Emission Tomography Images. IEEE transactions on medical imaging. 2022:submitted
• Silosky M and Chin BB. Modelling small lesion CNR in clinically relevant phantom studies. Journal of Nuclear Medicine. 2022;63:3204-3204
• Barilar M, Chin BB and Silosky M. Very small target detectability in 18F phantom studies: Effects of very small reconstruction voxel size and different reconstruction algorithms on contrast to noise ratio. Journal of Nuclear Medicine. 2022;63:4092-4092
• Chin BB, Silosky M, DeGrado T, Litwiller D and Xing F. List Mode Reconstructions of 68Ga DOTATATE PET / CT to Predict Contrast-to-Noise Ratio in Hepatic Metastases. Journal of Nuclear Medicine. 2022;63:4003-4003

Practice Locations

Specialty Information

• Nuclear Medicine, Board Certification